We came across a bullish thesis on Novo Nordisk A/S (NVO) on Substack by Felix. In this article, we will summarize the bulls’ thesis on NVO. Novo Nordisk A/S (NVO)’s share was trading at $64.49 as of ...

Today's Research Daily features new research reports on 16 major stocks, including The Procter & Gamble Company (PG), Novo ...

While much of the recent GLP-1 saga has been written in the U.S., Novo Nordisk continues to expand its semaglutide empire ...

Douglas McIntyre, Editor-in-Chief at Climate Crisis 24/7, reports that the city of Ann Arbor, Michigan, is exploring the ...

Novo, which had earlier planned for a 2026 launch ... US regulators deny rehearing on co-located Amazon data center energy pact 8:58 PM UTC · Updated ago Energycategory Chevron's Venezuelan ...

Eli Lilly launched its blockbuster diabetes and weight-loss drug Mounjaro in India on Thursday, beating rival Novo Nordisk ...

The market for anti-obesity drugs has been growing for a while, but is finally about to take off with the entry of two global ...

Helge Lund, its Chairman, will be stepping down after a “fundamental” strategy reset to cut renewable investments & grow ...

The Strategy trailed its core benchmark but bested its growth index, supported by strength among communication services and ...